• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Letter: Payer offers biased perspective on prior authorizations


A physician disagrees with the views of an insurance company spokesman regarding the need for prior authorizations.

In a recent edition of Medical Economics, you quote Edmund Pezalla, MD, of Aetna Inc. in a discussion regarding prior authorizations ("Prior authorizations: A payer's perspective," July 10, 2014).

He tells us that “until fairly recently most medical care was based on intuition and  guesswork.” I did not realize that I have been blundering in the dark for the last 20 years.

He also states that “we’re trying to make sure this is the right thing for the patient.” To think I imagined  that was my task. Clearly, patients need to be protected from my misguided ways.

The remainder of his remarks suggest that most physicians requests are for unusual or unproven tests. Ninety-nine percent of my applications are for CT [computerized tomography] or MRI [magnetic resonance imaging] scans, and precious few of these.

Apparently profit has no motive whatsoever in prior authorizations. 

I stand enlightened.

Russell Lee-Wood, MD
Barnesville, Ohio


Related Videos
Georges C. Benjamin, MD
Robert E. Oshel, PhD
Gary Price, MD, MBA
Gary Price, MD, MBA
Victor J. Dzau, MD, gives expert advice
Claire Ernst, JD, gives expert advice
Claire Ernst, JD, gives expert advice
Claire Ernst, JD, gives expert advice
Ron Holder, MHA, gives expert advice
remote patient monitoring
© 2023 MJH Life Sciences

All rights reserved.